Euroopa Kardioloogide Seltsi juhendmaterjal, tunnustanud ja kohandanud Eesti Kardioloogide
Selts, Eesti Laborimeditsiini Ühing ja Eesti Radioloogia Ühing.
Koosoleku protokoll:
- LDL-kolesterooli tulemusele täpsustava märkuse lisamine. Südamemarkerite töörühma otsus 24/01/2025
- Südamemarkerite töörühma koosoleku protokoll 23/03/2023
Kasulikud lingid:
-
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- 2023 ESC Guidelines for the management of acute coronary syndromes
- Natriuretic Peptide Assay Interference Table Designated by Manufacturer: Hemolysis and Biotin IFCC Committee on Clinical Applications of Cardiac Biomarkers (C-CB)
- BNP, NT-proBNP, and MR-proANP Assays: Analytical Characteristics Designated by Manufacturer IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB)
- Cardiac Troponin Assay Interference Table Designated by Manufacturer: Hemolysis and Biotin IFCC Committee on Clinical Applications of Cardiac Biomarkers (C-CB)
- High-Sensitivity* Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB)
- Point of Care Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB)